FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381930657> ?p ?o ?g. }

• W4381930657 endingPage "207" @default.
• W4381930657 startingPage "199" @default.
• W4381930657 abstract "Breast cancer is the most common cancer in women. The human epidermal growth factor receptor 2 (HER2) overexpressing subtype is related to poor prognosis with an aggressive phenotype and is reported as one of the most commonly seen subtypes. Trastuzumab is prevalently used as a treatment method for HER2+ breast cancer however, resistance to the drug frequently occurs following the treatment. MicroRNAs (miRNAs) are 19-23 nucleotide long small RNAs, which regulate gene expression at posttranscriptional level and studies show that there are differentially expressed miRNAs between drug sensitive and resistant groups, indicating that they might have some key roles in drug effectiveness. In this study, the aim is to find out the role of miR-216b-5p in trastuzumab resistance. SK-BR-3 cells developed resistance to trastuzumab after continuous treatment with increasing concentrations of the drug for 6 months. To investigate the effect of miR-216b-5p on cancer cell behavior in resistance state, proliferation, motility, and invasion capacities of these resistant cells were analyzed by xCELLigence real-time cell analyzer. To further understand the molecular mechanisms underlying the regulation of resistant SK-BR-3 cells by miR-216b-5p, microarray analysis was performed. Apoptosis analysis was also performed since the pathway enrichment analysis pointed out cell death related pathways. Th e proliferation, motility, and invasion capacities of the miR-216b-5p transfected resistant cells were diminished compared to sensitive cells. We identified the necroptosis signaling pathway as the result of microarray and pathway enrichment analyses. STAT1, IRF9, and PKR were validated as the significant elements of the pathway, which are also the putative targets of miR-216b-5p. Our apoptosis analysis showed that a significant amount of trastuzumab resistant SK-BR-3 cells entered to late apoptosis/necrosis stage upon miR- 216b-5p overexpression, it could be concluded that reexpression of miR-216b-5p sensitizes trastuzumab resistance through necroptosis in breast cancer." @default.
• W4381930657 created "2023-06-25" @default.
• W4381930657 creator A5011085827 @default.
• W4381930657 creator A5013829016 @default.
• W4381930657 creator A5057339894 @default.
• W4381930657 creator A5060879958 @default.
• W4381930657 creator A5077464953 @default.
• W4381930657 date "2023-01-01" @default.
• W4381930657 modified "2023-10-01" @default.
• W4381930657 title "miR-216b-5p promotes late apoptosis/necroptosis in trastuzumab-resistant SK-BR-3 cells" @default.
• W4381930657 cites W1980548655 @default.
• W4381930657 cites W1989739325 @default.
• W4381930657 cites W2015284016 @default.
• W4381930657 cites W2044702943 @default.
• W4381930657 cites W2072269334 @default.
• W4381930657 cites W2092585655 @default.
• W4381930657 cites W2095156669 @default.
• W4381930657 cites W2097255042 @default.
• W4381930657 cites W2104543633 @default.
• W4381930657 cites W2105549148 @default.
• W4381930657 cites W2117775530 @default.
• W4381930657 cites W2131994307 @default.
• W4381930657 cites W2145848169 @default.
• W4381930657 cites W2153032620 @default.
• W4381930657 cites W2159482845 @default.
• W4381930657 cites W2161574596 @default.
• W4381930657 cites W2169344919 @default.
• W4381930657 cites W2170989872 @default.
• W4381930657 cites W2259802687 @default.
• W4381930657 cites W2338586348 @default.
• W4381930657 cites W2592021046 @default.
• W4381930657 cites W2599342851 @default.
• W4381930657 cites W2761520461 @default.
• W4381930657 cites W2764335466 @default.
• W4381930657 cites W2767624974 @default.
• W4381930657 cites W2791389644 @default.
• W4381930657 cites W2791452587 @default.
• W4381930657 cites W2897054128 @default.
• W4381930657 cites W2901911383 @default.
• W4381930657 cites W2938987942 @default.
• W4381930657 cites W2979816505 @default.
• W4381930657 cites W2988477769 @default.
• W4381930657 cites W3025149516 @default.
• W4381930657 cites W3028304854 @default.
• W4381930657 cites W3048386181 @default.
• W4381930657 cites W3113211578 @default.
• W4381930657 cites W3126257602 @default.
• W4381930657 cites W3129087799 @default.
• W4381930657 cites W3148470348 @default.
• W4381930657 cites W3159505484 @default.
• W4381930657 cites W3163368161 @default.
• W4381930657 cites W3211851916 @default.
• W4381930657 cites W4211265581 @default.
• W4381930657 cites W4224981117 @default.
• W4381930657 doi "https://doi.org/10.55730/1300-0152.2655" @default.
• W4381930657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37529418" @default.
• W4381930657 hasPublicationYear "2023" @default.
• W4381930657 type Work @default.
• W4381930657 citedByCount "0" @default.
• W4381930657 crossrefType "journal-article" @default.
• W4381930657 hasAuthorship W4381930657A5011085827 @default.
• W4381930657 hasAuthorship W4381930657A5013829016 @default.
• W4381930657 hasAuthorship W4381930657A5057339894 @default.
• W4381930657 hasAuthorship W4381930657A5060879958 @default.
• W4381930657 hasAuthorship W4381930657A5077464953 @default.
• W4381930657 hasBestOaLocation W43819306571 @default.
• W4381930657 hasConcept C104317684 @default.
• W4381930657 hasConcept C114851261 @default.
• W4381930657 hasConcept C121608353 @default.
• W4381930657 hasConcept C145059251 @default.
• W4381930657 hasConcept C150194340 @default.
• W4381930657 hasConcept C186836561 @default.
• W4381930657 hasConcept C190283241 @default.
• W4381930657 hasConcept C2779786085 @default.
• W4381930657 hasConcept C31573885 @default.
• W4381930657 hasConcept C502942594 @default.
• W4381930657 hasConcept C530470458 @default.
• W4381930657 hasConcept C54355233 @default.
• W4381930657 hasConcept C62112901 @default.
• W4381930657 hasConcept C62478195 @default.
• W4381930657 hasConcept C8415881 @default.
• W4381930657 hasConcept C86803240 @default.
• W4381930657 hasConcept C94030615 @default.
• W4381930657 hasConcept C95444343 @default.
• W4381930657 hasConcept C96232424 @default.
• W4381930657 hasConceptScore W4381930657C104317684 @default.
• W4381930657 hasConceptScore W4381930657C114851261 @default.
• W4381930657 hasConceptScore W4381930657C121608353 @default.
• W4381930657 hasConceptScore W4381930657C145059251 @default.
• W4381930657 hasConceptScore W4381930657C150194340 @default.
• W4381930657 hasConceptScore W4381930657C186836561 @default.
• W4381930657 hasConceptScore W4381930657C190283241 @default.
• W4381930657 hasConceptScore W4381930657C2779786085 @default.
• W4381930657 hasConceptScore W4381930657C31573885 @default.
• W4381930657 hasConceptScore W4381930657C502942594 @default.
• W4381930657 hasConceptScore W4381930657C530470458 @default.
• W4381930657 hasConceptScore W4381930657C54355233 @default.
• W4381930657 hasConceptScore W4381930657C62112901 @default.

• next